RNALead
↗Toulouse, France
RNALead is a French biotechnology company specializing in next-generation RNA delivery solutions. The company was created in early 2025 as a spin-off to commercialize the FlashRNA® technology, a proprietary platform that utilizes non-integrative lentiviral particles (VLPs) to deliver multiple RNAs simultaneously for transient gene expression. Unlike traditional lipid nanoparticles (LNPs), FlashRNA® is designed to be non-immunogenic and highly efficient in targeting specific cell types in vivo.
The company's platform supports a wide range of therapeutic applications including immuno-oncology, vaccination, gene editing, and regenerative medicine. RNALead operates out of the Centre Pierre Potier in Toulouse and is currently advancing its lead clinical program, LymphARN, which aims to treat secondary lymphedema using a multi-factor RNA delivery approach.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:RNA Therapeutics & Delivery
SIZE & FINANCIALS
Employees:1-50
Founded:2025
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:TechLife Capital
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1 (LymphARN)
Modalities:RNA, VLP (Virus-Like Particles), Gene Therapy, Cell Therapy
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Flash BioSolutions (Technology Origin)
Key Partnerships:Inserm, Toulouse University Hospital, TheraLymph European Program
COMPETITION
Position:Emerging
Competitors:Moderna, BioNTech, Alnylam Pharmaceuticals, ReCode Therapeutics
LEADERSHIP
Key Executives:
Christine Duthoit - CEO & CSO
Valentin Alsat - COO & CFO
Scientific Founders:Christine Duthoit
Board Members:Jacques Rossignol (TechLife Capital), Jian Cao
LINKS
Website:rnalead.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with RNALead. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.